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Introduction
During embryonic development, emerging cell types often rely
on key cell-type specific transcription factors, the function of
which is to drive events to a differentiated state. Cell-type-
specific transcription factors act in combination with other
nuclear factors to alter the transcriptional state of the cell. One
important group of transcription factors generally associated
with the differentiation of neuronal and endocrine cell types
is the POU domain-containing proteins. POU domain
transcription factors are required for the differentiation of
various neuronal cell types in the brain, and in somatosensory,
vestibular/cochlear and visual systems (McEvilly and
Rosenfeld, 1999; Xiang et al., 1997). The importance of POU
domain proteins in neuronal differentiation has been firmly
established by phenotypic analysis of gain- and loss-of-
function mutants, and by molecular characterization of
their DNA-binding and transcriptional activation/repression
properties (McEvilly and Rosenfeld, 1999; Wegner et al.,
1993). In addition, a number of downstream target genes have
been identified that depend on POU domain transcription
factors for their normal neuronal expression. 
Despite this wealth of information, fundamental questions
concerning POU domain proteins and their roles in neuronal
differentiation have not been answered. To date there is no clear
understanding of the position of individual POU domain factors
in the gene regulatory network operating within any
differentiating neuronal cell type. Although in some cases
particular upstream and downstream genes have been identified
(Bermingham et al., 2002; Erkman et al., 2000; Mu et al., 2001;
Wagner et al., 2002), we have yet to achieve a clear picture of
how POU domain proteins alter the transcriptional states of
neuronal cells. We do not even know the number of genes in a
particular neuronal cell type that depend on an individual POU
factor for their expression. Because the transcriptome of any
neuronal cell type consists of thousands of expressed genes,
POU domain factors could be associated with a wide spectrum
of gene expression involving many different functional gene
classes. Alternatively, POU factors could act in more subtle
Brn3b/Brn-3.2/POU4f2 is a POU domain transcription
factor that is essential for retinal ganglion cell (RGC)
differentiation, axonal outgrowth and survival. Our goal
was to establish a link between Brn3b and the downstream
events leading to RGC differentiation. We sought to
determine both the number and types of genes that depend
on Brn3b for their expression. RNA probes from wild-type
and Brn3b–/– E14.5, E16.5 and E18.5 mouse retinas were
hybridized to a microarray containing 18,816 retina-
expressed cDNAs. At E14.5, we identified 87 genes whose
expression was significantly altered in the absence of Brn3b
and verified the results by real-time PCR and in situ
hybridization. These genes fell into discrete sets that
encoded transcription factors, proteins associated with
neuron integrity and function, and secreted signaling
molecules. We found that Brn3b influenced gene expression
in non RGCs of the retina by controlling the expression of
secreted signaling molecules such as sonic hedgehog
and myostatin/Gdf8. At later developmental stages,
additional alterations in gene expression were secondary
consequences of aberrant RGC differentiation caused by
the absence of Brn3b. Our results demonstrate that a small
but crucial fraction of the RGC transcriptome is dependent
on Brn3b. The Brn3b-dependent gene sets therefore
provide a unique molecular signature for the developing
retina.
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fashions, causing changes only in a limited number of functional
gene classes, leaving most of the transcriptome unaltered. 
We have made use of the retinal ganglion cell (RGC)-
specific POU domain transcription factor Brn3b/Brn-
3.2/POU4f2 to address issues of POU domain protein function
in neuronal cells. In the mouse, Brn3b (Pou4f2 – Mouse
Genome Informatics) is first expressed at E11.5 in newly
forming RGCs that have recently exited the cell cycle, and
although not required for the initial specification of RGCs,
Brn3b is essential for normal RGC differentiation, axonal
outgrowth and survival (Erkman et al., 1996; Erkman et al.,
2000; Gan et al., 1999; Gan et al., 1996; Wang et al., 2000).
Two related Brn3 factors, Brn3a and Brn3c, also play roles in
RGC differentiation (Wang et al., 2002a) (S. W. Wang,
unpublished), although only Brn3b-knockout mice produce a
detectable RGC phenotype. Thus, Brn3b can be used to
identify sets of genes that depend on a POU domain
transcription factor for their expression. 
Several genes whose expression in the retina is affected by
the absence of Brn3b have been previously identified (Erkman
et al., 2000; Mu et al., 2001), but given the limited scope of
these reports, these genes are unlikely to represent the full
spectrum of Brn3b function. We previously described the
construction of a large database of retina ESTs from E14.5
retinas and a pilot microarray analysis using 864 cDNAs to
screen for gene expression alterations in Brn3b–/– retinas (Mu
et al., 2001). We continue to expand our database, which
currently contains over 27,000 retina-expressed cDNAs
representing ~15,000 distinct genes (http://odin.mdacc.tmc.edu/
RetinalExpress). We estimate that the RetinalExpress database
currently contains 60-70% of the genes expressed in the E14.5
retina (Mu et al., 2001). 
The embryonic retina represents a tiny proportion of all the
tissues that form during the life of a mouse. We have argued
that retinal genes highly restricted in their expression will
generally be underrepresented in public databases and on
commercially available mouse microarrays (Mu et al., 2001).
For example, we have identified numerous genes that are
present in the RetinalExpress database but not in the 15K NIA
or 61K RIKEN mouse EST databases (Mu et al., 2001). Thus,
RetinalExpress provides a suitable platform to generate high-
density microarrays for use in identifying Brn3b-dependent
genes. Below, we describe the identification of Brn3b-
dependent genes by comparing expression profiles of wild-type
and Brn3b–/– retinas using microarrays containing 18,816
retina-expressed cDNAs. We find that highly restricted sets of
functional gene classes depend on Brn3b for their expression,
including genes that are expressed in non RGCs within the
retina. Our results demonstrate that Brn3b controls a small but
crucial fraction of the E14.5 retinal transcriptome. 
Materials and methods
RNA isolation and aRNA amplification from wild-type and
Brn3b–/– mice
Wild-type and Brn3b–/– mice were maintained in a BL6/129 mixed
background. The Brn3b–/– allele used in this study was the
Brn3bGFP-KI allele described elsewhere (Wang et al., 2002a). Wild-
type or Brn3b–/– embryos were obtained from pregnant females
euthanized after timed mating. Retinas from different embryonic
stages were dissected, and total RNA was isolated as described
previously Mu et al. (Mu et al., 2001). Total RNA was amplified by
the Eberwine method (Van Gelder et al., 1990) using the
MassageAmp aRNA kit (Ambion) following the manufacturer’s
instructions. One microgram of total retinal RNA was used for each
amplification, and typically, 50-100 m g of aRNA was obtained after
one round of amplification.
Fabrication and processing of retina-expressed cDNA
microarray slides
cDNA clones were obtained from the sequenced E14.5 retinal cDNA
library. Information on these clones can be found in the
RetinalExpress database (http://odin.mdacc.tmc.edu/RetinalExpress).
Gene identity of the clones was based mostly on Blastx search results.
cDNA inserts from individual clones were amplified in 96-well plates
using the T3 and T7 primers as described (Mu et al., 2001). The
amplified inserts were purified semi-automatically with the
MultiScreen PCR purification system (Millipore) on a Biomek 2000
robotic workstation. To each sample, 20 · SSC was added to a final
concentration of 3 · . The microarrays were printed on PL-100C
poly-L-lysine glass slides (CEL Associates) with the OmniGrid
microarrayer (Genemachine). A total of 18,816 clones were printed
on two slides, and each clone was printed in duplicate. The microarray
slides were processed by rehydration and snap-heating, followed by
incubation at 80°C for 1.5 hours to crosslink the DNA to the slide
surface. The DNA on the slides was then denatured in a 95°C water
bath for 2 minutes, rinsed with ethanol and air dried.
Probe labeling and microarray hybridization
aRNA was labeled by direct incorporation of Cy3- or Cy5-dUTP
(Amersham) through reverse transcription by SSII (Invitrogen) with
2 or 4 m g of aRNA and 6 m g random primers (Invitrogen) in 30 m l of
RT reaction mix (500 m M concentrations of dCTP, dATP and dGTP;
100 m M dTTP, 100 m M Cy3-dUTP or Cy5-dUTP; 400 U SSII; 1 mM
DTT; and 1 · RT buffer) at 37°C for 2 hours. The RT reactions were
terminated, and RNA degraded by addition of 1.5 m l of 0.5 N NaOH
and 1.5 m l of 20 mM EDTA (pH 8.0) and heating at 70°C for 10
minutes, followed by addition of 1.5 m l of 0.5 N HCl for
neutralization. The Cy3- and Cy5-labeled probes were purified
by GFX columns (Amersham Pharmacia) according to the
manufacturer’s manual, air dried in a SpeedVac, and resuspended in
15 m l of microarray hybridization buffer (see below) and combined.
Microarray hybridization basically followed the TIGR protocol
(Hegde et al., 2000) with minor modifications. The slides were first
incubated in pre-hybridization buffer (5· SSC, 0.1% SDS and 1%
BSA) at 42°C for 1 hour, followed by sequential rinsing in milliQ
water and isopropanol and air dried. The 30 m l Cy3- and Cy5-probe
mix in 1 · hybridization buffer [50% formamide, 5 · SSC, 0.1% SDS,
10 m g poly d(A) (Pharmacia) and 10 m g mouse Cot 1 DNA
(Invitrogen)] was applied to the microarray slide and covered with
HybriSlips (PGC Scientific). Hybridization reactions were carried out
in Corning hybridization chambers in a water bath at 42°C overnight.
The slides were then washed as follows: 1 · SSC, 0.2% SDS at 42°C
for 10 minutes; 0.1 · SSC, 0.2% SDS at room temperature for 10
minutes; and 0.1 · SSC at room temperature for 4 minutes. The slides
were air dried and scanned with a GenPix 4000A scanner (Axon) with
PMT settings of 500 to 650.
Microarray data collection and analysis
For each hybridized slide, two 16-bit TIFF images representing the
Cy3 and Cy5 channels were obtained. The median values of Cy3 and
Cy5 signals for individual spots were than obtained with GenPix Pro
4.0 from the TIFF images. The raw data were Lowess normalized
(Quackenbush, 2002) and further analyzed with Genespring 5.0
(Silicon Genetics). For normalization, a Lowess curve was fit to the
log-intensity versus log-ratio plot. Twenty percent of the data were
used to calculate the Lowess fit at each point. This curve was used to
adjust the control value for each measurement. If the control channel
was lower than 10, then 10 was used instead. Significance of
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differentially expressed genes was analyzed by Student’s t-test with
Genespring 5.1. 
To compare gene expression changes between different
developmental stages, genes with significant changes in all stages
(E14.5, E16.5 and E18.5) were combined and the average values for
replicate experiments were used to create a clustering gene tree using
GeneSpring 5.1 based on similarity of gene expression patterns, which
was determined by using the standard correlation and program
defaults for separation ratio and minimum distance. 
Real-time PCR and data analysis
Real-time PCR was performed on an iCycler (BioRad). Four
micrograms of total RNA was first reverse transcribed with SSII and
oligo dT primer in a total volume of 20 m l for 2 hours at 42°C. SSII
was inactivated by heating at 75°C for 15 minutes, The cDNA was
diluted 10 fold, and 1-5 m l was used for each 50 m l PCR using
the iQ SYBR Green Supermix (BioRad). The primer sequences
can be found in the supplemental data (see Table S1 at
http://dev.biologists.org/supplemental. The PCR conditions for all
genes were as follows: preheating, 95°C for 3 minutes; cycling, 40
cycles of 94°C for 30 seconds and 50°C for 30 seconds; and 72°C for
40 seconds. For each gene, the real-time PCR assay was performed
twice with two different batches of total RNA. The b -actin gene
served as an RNA input control.
Fold changes of gene expression were calculated based on the cycle
differences between wild-type and Brn3b–/– samples as compared to
the b -actin control using the following formula: FC=2 D MT-D WT, where
FC is fold change, D MT is the difference of cutoff cycles between the
gene of interest and the control gene ( b -actin) for the Brn3b–/– and
D WT is that for wild type.
In situ hybridization
Purified PCR products containing T3 and T7 primer sequences (see
above) for genes of interest were used as templates, and DIG-labeled
antisense RNA probes were made by in vitro transcription with T7
RNA polymerase (Ambion) and purified by ethanol precipitation.
Heterozygous and Brn3b–/– embryos were collected at E14.5, fixed
with 4% paraformaldehyde, paraffin-embedded, and sectioned at 6
m m. The sections were de-waxed and treated with proteinase K. For
each gene, sections from littermates with different genotypes were
used, and hybridization was performed side by side. Efforts were
made to use sections from similar section planes for individual
genes. Hybridization incubations were carried out in hybridization
buffer [50% formamide, 5 · SSC (pH 4.5-5.0), 1% SDS, 50 m g /ml
yeast tRNA, 50 m g/ml heparin] at 65°C overnight, followed by three
30-minute washes with pre-warmed washing buffer [50%
formamide, 1 · SSC (pH 4.5-5.0), 1% SDS] at 65°C. The slides were
then incubated with alkaline phosphatase-conjugated anti-DIG
antibody (Roche) in 1 · MABT (100 mM maleic acid, 150 mM NaCl,
0.1% Tween 20, pH 7.5), 2% BRB (Roche) and 10% goat serum
overnight at room temperature. After being washed five times (30
minutes each) with MABT buffer and once with NTMT [100 mM
Tris-HCl (pH 9.5), 100 mM NaCl, 50 mM MgCl2, 0.1% Tween 20
and 0.048% levamisole], hybridization signals were visualized by
incubating with BM Purple (Roche) at room temperature for the
desired time. The slides were then counterstained with eosin and
photographed.
Electrophoretic mobility shift assay
EMSA with GST-3bPOU was performed as described (Gruber et al.,
1997). For supershift, 1 m l of anti-GST antibody (Promega) was added
to the binding reaction. The sequences for the SBRN3 probe were:
5¢ GCACACGACCCAATGAATTAATAACCGGGCTG 3 ¢ and 5¢
GCAGCCCGGTTATTAATTCATTGGGTCGTGTG 3 ¢ . The Brn3
consensus competitor oligonucleotide sequences were: 5 ¢ GATCT-
CTCCTGCATAATTAATTACCCCCGGAT 3 ¢ and 5¢ GATCCGG-
GGGTAATTAATTATGCAGGAGAGAT 3¢ .
Cell culture, cell transfection and luciferase assay
HEK 293 cells were cultured in DMEM with 10% FBS at 37°C with
5% CO2. To generate the luciferase reporter construct, the conserved
sonic hedgehog region in the first intron was amplified by PCR from
mouse genomic DNA and inserted upstream of the minimal rat
prolactin promoter (–36prl) driving firefly luciferase expression (Trieu
et al., 1999). A mutant version of this Shh reporter construct was made
by PCR, mutating all the essential nucleotides in the Brn3b-binding
site from ATGAATTAAT to GCGCGTTGAC. The Brn3b expression
construct was made by placing the Brn3b cDNA under the control of
the CMV promoter. Transfection was carried out in six-well plates
using FuGene (Roche) following the manufacturer’s protocol. For
each transfection, 10 ng of reporter plasmid, 1 m g of Brn3b expression
plasmid or empty vector, and 1 ng of pRL-CMV (Promega) expressing
Renilla luciferase was used. Cells were harvested 36 hours after
transfection, and luciferase activity was measured by the Dual-
Luciferase Reporter Assay System (Promega). The firefly luciferase
activity was normalized to Renilla luciferase activity. 
Results
Identification of Brn3b-dependent retina-expressed
genes at E14.5
We chose E14.5 as the most crucial developmental time to
compare expression profiles from wild-type and Brn3b–/–
retinas for two reasons. First, at E14.5 RGC differentiation is
at its peak, while other cell types have either just begun to
differentiate or have not yet begun. Thus, at E14.5, most cells
in the retina are either newly formed RGCs within the ganglion
cell layer or neuroblasts in various states of commitment in the
proliferation zone above the ganglion cell layer. Second, at
E14.5, although mutant RGCs are abnormal in appearance and
behavior, the number of differentiated RGCs is the same in
Brn3b-null retinas as it is in wild-type controls (Gan et al.,
1999; Wang et al., 2000). At later times, Brn3b–/– RGCs
undergo enhanced apoptosis, and by P0, the number of RGCs
in mutant retinas is 70% less than controls (Gan et al., 1999;
Wang et al., 2000). Using RNA from E14.5 thus maximizes the
chances of identifying Brn3b-dependent genes while avoiding
potential secondary effects from the loss of RGCs observed in
later stage mutant retinas. 
Three pairs of wild-type and Brn3b–/– antisense RNA
(aRNA) samples amplified from independent retinal total RNA
preparations were labeled by reverse transcription with Cy3 or
Cy5 dyes; duplicate experiments were performed for each pair
either by exchanging the labeling dye (two pairs) or varying
the amount of probe (one pair). In total, six different
experiments were performed with replicate microarrays
containing 18,816 retina-expressed cDNAs. In all cases,
greater than 90% of the spotted cDNAs yielded signals above
background. In rare occurrences, dye exchange led to
significant differences between wild-type and Brn3b–/– signals
but these were discounted. After Lowess normalization with
Genespring 5.0, the ratio of wild-type to mutant signal was
obtained for each cDNA spot in all six experiments. cDNA
clones with ratios or inverse ratios of 1.7 or higher in at least
four experiments were considered to represent significant
changes in expression as measured by Student’s t-test (Table
1). We chose 1.7-fold change as our empirical cut-off because
smaller cut-off values greatly increase the number of false-
positive clones. 
The analysis produced 157 cDNAs that met the above-
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mentioned criteria, with expression ratios ranging from 1.7 to
13.6, but because some genes were represented by multiple
clones, this number fell to 87 distinct cDNAs. One of these was
Brn3b, which validated the usefulness of the hybridization
procedure. Of the remaining 86 cDNAs, 63 were
underexpressed in Brn3b–/– RNA and 23 were overexpressed.
The cDNAs were distributed into 48 known genes and 38
unknown ESTs. The known genes included not only genes
whose functions have been well studied, but also those whose
full-length cDNA sequence is known but whose function is not
(Table 1). The unknown genes represented uncharacterized
sequences that were found only in public EST databases or
in the mouse genome sequence. A few of these cDNAs
probably represented 3 ¢ UTRs of known genes that have no
Development 131 (6) Research article
Table 1. Known genes whose expression changes in the absence of Brn3b
Accesssion Number* Gene name FC† FC (PCR)‡ p-value§ SE¶
Transcription factors
S69351 Brn3b/Brn-3.2/Pou4f2 –5.06 – 0.000 RGC
L12147 Olf-1/EBF1 –4.27 –8.0 0.000 RGC
S69350 Brn3a/Brn-3.0/Pou4f1 –3.82 –4.6 0.000 RGC
AF295369 Irx2 –3.81 –5.7 0.000 RGC
AB025922 Gli1 –2.99 –6.1 0.000 Progenitor
AB015132 Ubiquitous Kruppel like factor –1.87 ND 0.000 Unknown
U51000 Dlx-1 2.18 4.0 0.002 Progenitor
NM_009380 Thyroid T3 hormone receptor beta 2.91 ND 0.001 Non-RGC
NM_010054 Dlx-2 NA 2.8 Progenitor
Neuron integrity and function
AF099986 Persyn/synuclein- g –13.60 –42.2 0.000 RGC
S59158 EAAT-2/GluT1 –3.83 –6.9 0.000 Non-RGC
NM_013031** VMAT-2 –3.00 –16.0 0.000 RGC
J02809 GAP-43 –2.99 –2.1 0.000 RGC
U10355 Synaptotagmin 4 –2.73 –6.9 0.000 RGC
AF148511 Hermes –2.53 –4.9 0.000 RGC
M20480 Neurofilament light chain –2.48 –3.7 0.000 RGC
AF091342 Nerurofilament medium chain –2.41 –2.6 0.000 RGC
U62325 FE65-like protein –2.35 ND 0.000 Unknown
M16465 Calpactin I light chain –2.30 –5.3 0.000 Unknown
AB048947 Synaptotagmin 13 –2.30 ND 0.000 RGC
U59230 Nel-like 2 (nell2) –2.19 –16.0 0.000 Unknown
D50086 Neuropilin 1 –1.96 –2.6 0.000 Unknown
M18776 Tau microtubule binding protein –1.83 –2.4 0.000 RGC
AY043013†† Neuron navigator 1 (NAV1) 1.95 ND 0.002 Unknown
Signaling and cell cycle
X76290 Sonic hedgehog NA –78.8 RGC
AF033855 Myostatin/GDF8 –2.05 –12.1 0.000 RGC
AB010833 Ptc2 NA –4.9 Progenitor
S78355 Cyclin D1 –2.50 –2.4 0.000 Progenitor
Others
D45913 Leucine-rich-repeat protein –2.46 ND 0.000 Unknown
AF292939 Glucocorticoid induced gene 1, Gig1 –2.33 –2.0 0.000 Unknown
AP001748 U2 snRNP auxiliary factor –2.25 ND 0.000 Unknown
BC001993 Protein phosphatase 4 –2.18 ND 0.000 Unknown
BC017139 RIKEN 2310067G05 gene –2.15 ND 0.000 Unknown
NM_145377 Tripartite motif-containing 41 –2.12 ND 0.000 Unknown
XM_196206 RIKEN 2610209L21 gene –2.11 ND 0.000 Unknown
AF012271 Visual pigment-like receptor –2.10 ND 0.000 Unknown
AJ414378 Putative methionyl aminopeptidase –2.00 ND 0.000 Unknown
D13635†† Ubiquitin-protein isopeptide ligase E3 –1.98 ND 0.000 Unknown
XM_128169 RIKEN 1810041L15 gene (RGCG1) –1.91 –2.6 0.000 RGC
AB051466 KIAA1679 protein –1.87 ND 0.000 Unknown
U17259 p19 –1.86 ND 0.001 Unknown
U17599 Ribonucleoprotein –1.80 –2.6 0.000 Unknown
Y15924 Cystinosin –1.76 ND 0.000 Unknown
AH009472 Phosphofructokinase 1 C isozyme –1.71 ND 0.001 Unknown
M17300 Cholesterol-regulated protein C –1.70 ND 0.000 Unknown
AE003460 MTMR6 1.63 ND 0.002 Unknown
Z49204 NADP transhydrogenase 1.85 1.9 0.001 Unknown
BC006058 RIKEN 2510049I19 gene 1.92 ND 0.001 Unknown
NM_025940 RIKEN 2610042L04 gene 2.52 2.3 0.001 Unknown
*GenBank Accession Number. Rat (**) or human (††) Accession Numbers are shown for genes without a mouse entry in GenBank.
†Average fold change from microarray experiments. Negative numbers mean reduction in expression in the absence of Brn3b and positive numbers mean
increase in expression.
‡Fold change determined by real-time PCR. ND, not determined.
§P value (Student’s t-test) based on the microarray data. The value is presented as 0.000 when it is less than 0.0005.
¶Spatial expression pattern.
1201Brn3b-dependent retinal gene expression
representation in other databases, but most of them were
likely to represent novel cDNAs that have not been identified
previously, as they were not near known genes in the mouse
genome (data not shown). Because we wished to determine
whether Brn3b-dependent genes belonged to specific
functional classes, we mainly focused our analysis on genes
that had already been characterized. In any event, the results
from the microarray analysis were surprising because
they revealed that only a small proportion of the expressed
genes in the E14.5 retina depended on Brn3b for their
expression. 
The replicate experiments were highly reproducible with
only minor variation from one experiment to the next. This
suggested that most of the genes represented on the microarray
and dependent on Brn3b for their normal levels of
expression were identified in the analysis. In
addition, because the cDNAs spotted on the
microarray represented ~50% of all E14.5 retina-
expressed genes, we expect that additional Brn3b-
dependent genes will be identified when more
cDNAs are added to the microarray. In fact, we
identified three genes not present on the existing
microarrays based on their relationships to genes
found in the present analysis (Table 1, see below). 
A subset of genes showing 1.7 fold or greater
differences in expression levels between wild type
and Brn3b–/– retinas were subjected to real-time
PCR analysis. Real-time PCR plots for 14
representative examples are displayed in Fig. 1,
and fold changes for 28 genes are summarized in
Table 1. The ratios ranged from >80-fold
underexpressed in the case of sonic hedgehog
(Shh) to fourfold overexpressed in the case of
Dlx1. In general, the fold changes observed by
real-time PCR tended to be larger than those from
the microarray experiments, probably because of
the limited dynamic range of the microarray
hybridization (Livesey et al., 2000). 
Discrete functional sets of Brn3b-
dependent genes
Brn3b-dependent genes listed in Table 1 include
genes that were previously reported to have altered
expression in Brn3b–/– retinas including Gap43
(Mu et al., 2001), Olf1/Ebf1 (Erkman et al., 2000)
and Brn3a (Wang et al., 2002a). All three genes
were significantly downregulated in the absence of
Brn3b. The cellular functions of these genes
provided initial clues for explaining the defects
observed in Brn3b-null RGCs and unraveling the
role of Brn3b in RGC differentiation. As we
discuss below, transcription factors and proteins
associated with neuron integrity and function
represent major classes of Brn3b-dependent
genes. 
Fig. 1. Real-time PCR confirming the expression
changes of subsets of genes in Brn3b–/– retina. The x-
axis is relative fluorescence units (RFU), indicating
PCR product accumulation, and the y-axis indicates
PCR cycles. Wild type is red and Brn3b–/– is green. b -
actin serves as an RNA input control. Syntg4 is
synaptotagmin 4. The accumulation of fluorescence for
Brn3b in the Brn3b–/– sample near the end of the
reaction is due to nonspecific amplification, as
confirmed by the melting curve and agarose gel
electrophoresis (data not shown). Fold changes
obtained by real-time PCR are shown in Table 1.
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Brn3b-dependent genes encoding transcription
factors
Genes encoding transcription factors that were identified in the
microarray analysis as underexpressed in Brn3b–/– retinal RNA
were Olf1/Ebf1, Brn3a, Irx2, Gli1 and ubiquitous Krupple-like
factor. Transcription factor genes that were overexpressed were
Dlx1, Dlx2, and thyroid receptor-b (TR-b ). With the exception
of the gene encoding ubiquitous Krupple-like factor, about
which very little is known, the identified genes all have known
or postulated roles in the retina. 
Olf-1/Ebf1 belongs to a bHLH transcription factor family
that also includes Olf2/Ebf2 and Olf-3/Ebf3. The genes
encoding these factors are expressed in many post-mitotic
neurons during development, including RGCs, suggesting they
have a role in neuronal differentiation (Dubois and Vincent,
2001). However, elucidation of their function has been
hindered by the potential overlap of the three genes (Dubois
and Vincent, 2001). 
Brn3a is likely to be a direct target of Brn3b because brn3a
expression in RGCs immediately follows that of Brn3b and the
Brn3a promoter has Brn3 DNA-binding sites that can stimulate
reporter gene transcription when co-transfected into tissue
culture cells with Brn3b (Trieu et al., 1999). Although Brn3a–/–
retinas appear to be normal, Brn3a-Brn3b double knockout
mice exhibit a more severe RGC phenotype than do Brn3b–/–
mice, suggesting that Brn3a partially compensates for the loss
of Brn3b (S. W. Wang, unpublished). 
Irx2 is one of six members of a mammalian homeobox
family related to the Drosophila genes of the iroquois complex.
Another member, Irx6, which was not included in our array
set, has been previously identified as a Brn3b-dependent gene
(Erkman et al., 2000). All six Irx genes are expressed in RGCs
during development, but their roles in RGC differentiation are
unclear (Cohen et al., 2000; Mummenhoff et al., 2001). A
recent report suggests that Irx4 is involved in RGC axon
pathfinding within the retina through regulating Slit1
expression (Jin et al., 2003). Not all Irx genes depend on Brn3b
for their expression in RGCs; we observed no alterations in
expression of Irx5, a cDNA that was represented on the retinal
cDNA microarray.
Dlx1 and its closely linked relative Dlx2 are homologs of the
Drosophila homeobox gene distal-less, and they function to
downregulate the Notch signaling pathway in neuronal
specification and differentiation of the telencephalon (Yun et
al., 2002). The strong upregulation of Dlx1 in the absence of
Brn3b prompted us to examine the expression of Dlx2, which
is linked to Dlx1 and may be co-regulated with Dlx1 through
common cis-regulatory elements (Panganiban and Rubenstein,
2002). Like Dlx1, we found that Dlx2 was also overexpressed
in Brn3b–/– RNA (Table 1; Fig. 1). The Notch pathway is
crucial for patterning the vertebrate retina and negatively
regulating RGC formation (Austin et al., 1995; Dorsky et al.,
1995). It is possible that Brn3b is involved in controlling RGC
number by negatively regulating Dlx1 and Dlx2. If this were
true, Dlx1 and Dlx2 expression should be upregulated in
Brn3b–/– RGCs at E14.5. In situ hybridization of sections from
Brn3b+/– and Brn3b–/– E14.5 embryos showed that Dlx1
expression was much higher in Brn3b–/– retinas than in
Brn3b+/– retinas (Fig. 2B), supporting the view that Brn3b
negatively controls Dlx1 expression. Notably, Dlx1 expression
was higher in progenitor cells as well as RGCs (Fig. 2B),
suggesting that the action of Brn3b might be indirect (see
below).
TR- b is a member of the nuclear receptor family, and one of
its isoforms TR-b 2 is required for the specification of S-cone
cells in the photoreceptor layer (Ng et al., 2001). Because
Brn3b is expressed exclusively in RGCs of the retina, its effects
on TR-b were unexpected and must be indirect. Although we
cannot yet provide an explanation for the upregulation of TR-
b in the absence of Brn3b, it is possible that Brn3b influences
TR-b expression in S-cone cell progenitors by regulating genes
encoding secreted molecules as discussed below. 
Brn3b-dependent genes encoding proteins
associated with neuron integrity and function
Consistent with the axonal defects of Brn3b–/– RGCs, a
battery of neuron-specific cytoskeletal/structural genes were
downregulated in Brn3b–/– retinas (Table 1; Fig. 2C). The
genes encode neurofilament light chain (Nfl), neurofilament
middle chain (Nfm), Tau and persyn. Nfl and Nfm are
embryonically expressed proteins that form neurofilaments
with the postnatally expressed neurofilament heavy chain (Nfh)
(Julien, 1999). Tau is a neuron-specific microtubule-associated
protein (Garcia and Cleveland, 2001). Persyn (also known as
synuclein-g ) belongs to the synuclein family and its gene had
the most pronounced reduction in expression in the microarray
analysis with a ratio of wild-type to mutant expression of 13.6
(Table 1; Fig. 1, Fig. 3C). The other two members of the family,
synuclein-a and synuclein- b , are presynaptic proteins that have
been implicated in synaptic function and Alzheimer’s disease
(Lavedan, 1998), whereas persyn is localized throughout the
cell and appears to associate with neurofilament proteins.
Overexpression of persyn disturbs the integrity of the
neurofilament network (Buchman et al., 1998). 
Knockout mice have been generated for several of the above-
mentioned genes, but none produced observable neuronal
defects, despite being crucial cytoskeletal or structural
elements in neuronal cells (Garcia and Cleveland, 2001; Julien,
1999; Ninkina et al., 2003). Compensatory mechanisms, which
are largely due to redundancy of related gene family members,
are likely to explain the lack of axonal or other neuronal
phenotypes. Nevertheless, in the absence of Brn3b, the
concerted reduction in expression of several distinct structural
components likely contributed to the axonal defects observed
in Brn3b–/– retinas. 
Only a subset of neuron-specific cytoskeletal/structural
proteins were identified by our analysis despite the presence
of many other neuron-specific genes represented on the
microarray. For example, the gene encoding neurofilament 66
(Nf66, also known as a -internexin) is expressed specifically in
RGCs of the retina (Levavasseur et al., 1999), but Nf66
expression levels were unaffected by the absence of Brn3b
(Fig. 2A). Because Nf66 expression served as a marker for the
presence of RGCs, comparable levels of Nf66 transcripts in
Brn3b heterozygous and homozygous mutant E14.5 retinas
further confirmed that, at this developmental time, RGC
number was not significantly reduced in Brn3b–/– retinas
compared with heterozygous controls (Fig. 2A). 
In addition to genes encoding neuron-specific cytoskeletal/
structural proteins, two genes encoding proteins associated
with axon guidance were found to be dependent on Brn3b for
their normal expression: neuropilin 1 and Gap43 (Table 1; Fig.
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1, Fig. 2C). Although our retina-expressed cDNA microarray
included genes for several classes of axon guidance ligands and
their receptors, only the genes encoding neuropilin 1 and
Gap43 were significantly downregulated in Brn3b–/– retinas.
Neuropilin 1 complexes with plexins to serve as receptors for
class III semaphorins (He et al., 2002). Neuropilin 1 has been
implicated in RGC axon guidance at both the optic disc and
optic chiasm in Xenopus (Campbell et al., 2001). Gap43 also
functions in RGC axons at the optic chiasm. Downregulation
of the two axon guidance genes is consistent with the
pathfinding defects observed in Brn3b-null RGC axons
(Erkman et al., 2000; Wang et al., 2002a). 
Axon guidance and the establishment of the axonal
cytoskeletal network are two inseparable aspects of axon
growth during neuron development. Growing axons respond to
guidance cues by remodeling the cytoskeleton at growth cones
(Grunwald and Klein, 2002). Our results suggest that Brn3b
plays a central role in both aspects of RGC axon growth by
regulating the expression of a subset of the critical genes. 
Expression of Brn3b persists in RGCs throughout adult life,
suggesting that it might also function to regulate genes
involved in RGC physiologic integrity. This idea was supported
by the identification of several Brn3b-dependent genes
involved in physiological processes. These include genes
encoding two neurotransmitter proteins Eaat2/Glut1 and
Vmat2 (Table 1; Fig. 1). Eaat2/Glut1 is a Na+/K+-dependent
glutamate transporter belonging to the plasma membrane
neurotransmitter transporter family, and Vamt2 is a vesicular
monoamine transporter of the vesicular neurotransmitter
transporter family (Masson et al., 1999). Both play important
roles in synaptic signal transduction. 
Three other genes that depended on Brn3b for their normal
expression appear to be associated with RGC function. These
genes encode synaptotagmin 4, synaptotagmin 13 and
calpactin (Table 1; Fig. 1, Fig. 2C). Most members of the
synaptotagmin family are calcium sensors for neurotransmitter
release at synapses (O’Connor and Lee, 2002). However,
synaptotagmin 13 lacks the key amino acid residues required
to bind Ca2+ ion (von Poser and Sudhof, 2001), while
synaptotagmin 4 is mostly localized within the cell body and
growth cones, suggesting that this protein may have
nonsynaptic functions, perhaps in neurite growth (Ibata et al.,
2002). Calpactin forms complexes with many proteins at the
plasma membrane. Calpactin is a subunit of annexin II, which
functions in neurite growth (Hamre et al., 1995), and it is also
an auxiliary protein that associates with two different ion
channels (Girard et al., 2002; Okuse et al., 2002). Calpactin
thus appears to have both differentiation and physiological
functions. 
We identified several Brn3b-dependent genes whose
Fig. 2. In situ hybridization for subsets
of genes reveals that these genes
depend on Brn3b for expression in the
retina through both cell-autonomous
and non-cell-autonomous mechanisms.
DIG-labeled probes for individual
genes were hybridized to E14.5 Brn3b
heterozygous (+/–) and null (–/–)
sections across the eye. (A) Consistent
with the microarray results, expression
of the RGC-specific neurofilament 66
gene (Nf66) was not dependent on
Brn3b. (B) Two examples, Dlx1 and
cyclin D1 (Clnd1), whose expression
did not coincide with Brn3b but was
affected by the absence of Brn3b. In
the heterozygous retina, both Dlx1 and
cyclin D1 were expressed mostly in the
progenitor cell layer. In the Brn3b–/–
retina, Dlx1 was upregulated, most
prominently in the RGCs, while cyclin
D1 was downregulated. (C) Five
examples RGC-specific genes
downregulated in the absence of
Brn3b: Gap43, synaptotagmin 13
(Syt13), neurofilament light-chain gene
(Nfl), Hermes and myostatin/Gdf8.
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expression was not restricted to neuronal cells but nonetheless
were likely to participate in retinal function. Cyclin D1, the
only cell cycle gene to be identified in the microarray analysis,
was significantly downregulated in the absence of Brn3b (Table
1; Fig. 1, Fig. 2B). Cyclin D1, which promotes progression
through the G1 phase of the cell cycle, is abundantly expressed
in the E14.5 retina, and is required in the retina for cell
proliferation and photoreceptor cell survival (Dyer and Cepko,
2001; Ma et al., 1998). Cyclin D1 was expressed mostly in
progenitor cells in Brn3b heterozygous retinas at E14.5 and its
expression was uniformly reduced in Brn3b-null retinas (Fig.
2B). This result suggests that Brn3b can influence progenitor
cell proliferation through cyclin D1. As with Dlx1 and Gli1
(see below), the influence of Brn3b on cyclin D1 expression in
non RGCs must be indirect. 
Hermes is an RNA-binding protein that is strongly
downregulated in the absence of Brn3b (Table 1; Fig. 1, Fig.
2C). It is expressed in the developing heart and in RGCs of the
retina, but its function is currently not known (Gerber et al.,
1999). In RGCs, it may participate in the localization of
mRNAs whose encoded proteins are required for normal
neurite growth and function. 
We also identified a number of uncharacterized genes
whose normal expression levels depend on Brn3b (Table 1).
Although the roles that these genes play in the retina have not
yet been elucidated, some of them would be expected to be
RGC-specific and have novel retinal functions. For example,
we identified a cDNA, Rgcg1, that is identical to the RIKEN
mouse cDNA 1810041L15 (Accession Number,
XM_205822). The Rgcg1 gene encodes a predicted 15.9 kDa
protein with no recognizable motifs, but an orthologous
Rgcg1 exists in the human genome. Fig. 3A shows that in
wild-type sections, Rgcg1 was expressed specifically in
RGCs within the retina and in the olfactory epithelium. In
Brn3b–/– sections, expression of Rgcg1 was largely absent in
RGCs but was undisturbed in the olfactory epithelium (Fig.
3A). These results identify a new RGC-specific gene and also
demonstrate that Brn3b-dependent genes can be expressed
outside the retina by mechanisms independent of Brn3b.
Below, we discuss further examples of Brn3b-independent
expression. 
Brn3b-dependent genes encoding secreted
signaling molecules
The microarray analysis unexpectedly revealed that the
gene encoding myostatin/Gdf8, a member of the TGF- b
superfamily, was significantly underrepresented in Brn3b–/–
retinal RNA (Table 1). Furthermore, real-time PCR showed
that myostatin/Gdf8 transcripts were 12-fold reduced in
Brn3b–/– RNA (Table 1; Fig. 1). Myostatin/Gdf8 is a potent
negative regulator of skeletal muscle differentiation but is also
strongly expressed in the CNS (McPherron et al., 1997). Our
results suggest that myostatin/Gdf8 may have a function in
RGCs. In situ hybridization showed that myostatin/Gdf8
expression in the retina was confined to RGCs in Brn3b
heterozygous embryos, and that expression was largely absent
in Brn3b–/– retinas (Fig. 2C). Based
on its role in skeletal muscle,
myostatin/Gdf8 could be secreted
from RGCs into the extracellular
retinal environment and negatively
impact the differentiation of retinal
cell types by preventing progenitor
cells from exiting the cell cycle.
Myostatin/Gdf8 might play an
analogous role to Gdf11, the close
homolog of myostatin/Gdf8, which
functions as a negative feedback
signal in neuronal progenitors of the
olfactory epithelium to inhibit the
generation of new neurons (Wu et al.,
2003).
Because Gli1 expression levels
were reduced in Brn3b–/– retinas
(Table 1; Fig. 4A,B), and Gli1 is a
known component of the Shh
signaling pathway, we used real-time
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Fig. 3. Brn3b-dependent genes require
Brn3b for expression only in the retina.
Shown here are four genes (A, Rgcg1; B,
synaptotagmin 4; C, persyn; D, Brn3a)
whose expression was downregulated in
the RGC layer in Brn3b-null (–/–) when
compared with the heterozygous retina
(+/–), but was not changed in other
tissues. NC, nasal cavity; R, retina;
DRG, dorsal root ganglia; SC, spinal
cord.
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PCR to determine whether Shh expression was altered in the
absence of Brn3b. We found that Shh levels were reduced about
80-fold in Brn3b–/– retinal RNA (Table 1; Fig. 4A). We discuss
the significance of this result below but the identification of
myostatin/Gdf8 and Shh as Brn3b-dependent genes indicates
that Brn3b can exert its function in a cell non-autonomous
fashion through the action of secreted signaling molecules. 
Genes dependent on Brn3b in RGCs may be
expressed independently of Brn3b in non-retinal
tissues
Most of the Brn3b-dependent genes that we identified are also
expressed outside the retina. Non-retinal expression occurs in
tissues both where Brn3b is and is not expressed. In both cases,
expression of Brn3b-dependent genes was affected only in the
retina of Brn3b–/– mice. For example, Brn3a, persyn and
synaptotagmin 4 were expressed in dorsal root ganglia where
Brn3b is also expressed and in the spinal chord where Brn3b
is not expressed (Fig. 3B-D). In the absence of Brn3b,
expression was reduced in RGCs but unaffected in the dorsal
root ganglia and spinal chord (Fig. 3B-D). Similarly,
expression of Rgcg1 was reduced in RGCs of Brn3b-mutant
embryos but was not reduced in the olfactory epithelium where
Brn3b is not expressed (Fig. 3A). The results imply that
expression of Brn3b-dependent genes is controlled by Brn3b
only in the retina and that their expression must be regulated
by different mechanisms in other tissues.
The Shh pathway in the retina is controlled by Brn3b
The hedgehog pathway is conserved in most metazoan
organisms and is involved in diverse roles in pattern formation
and cell differentiation during development (Ingham and
McMahon, 2001). In mice, Shh, the major hedgehog factor,
binds to its receptors patched 1 (Ptch) or patched 2 (Ptch2),
which in turn derepress Smoothend (Smo) to regulate the
activity of the effector transcription factors Gli1, Gli2 and Gli3.
During retinal development, Shh is expressed in RGCs as they
commit to their fate (Neumann and Nuesslein-Volhard, 2000;
Wang et al., 2002b; Zhang and Yang, 2001a; Zhang and Yang,
2001b). Other members of the pathway, namely, Ptch, Ptch2,
Smo, Gli1, Gli2 and Gli3, are expressed in retinal progenitor
cells (Nakashima et al., 2002) (Fig. 4B). In the retina, Shh is
required for the autoregulation of RGC number (Zhang and
Yang, 2001a) and retinal patterning (Neumann and Nuesslein-
Volhard, 2000; Wang et al., 2002b). It has also been shown
recently that Shh from RGCs is required for optic disc and stalk
neuroepithelial cell development (Dakubo et al., 2003). The
observation that Gli1, a direct target of Shh signaling, was
downregulated in progenitor cells of Brn3b–/– retinas (Fig. 4B),
suggested that Shh expression might also depend on Brn3b.
Fig. 4. The sonic hedgehog pathway is disrupted in Brn3b–/– retinas. (A) Real-time RT-PCR analysis of genes belonging to the sonic hedgehog
pathway. Red is for wild-type and green is for Brn3b–/–. b -actin was used as RNA input control. Three genes, sonic hedgehog (Shh), Gli1 and
patched 2 (Ptch2), were significantly downregulated in Brn3b–/– retina, while other genes showed no change. (B) In situ hybridization of Shh,
Gli1 and Smo on E14.5 Brn3b heterozygous (+/–) and null (–/–) sections. Gli1 and Smo were expressed in progenitor cells and Shh in RGCs.
Gli1 and Shh were downregulated in Brn3b–/– retinas, while Smo showed no change. 
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This scenario was confirmed by real-time PCR (Fig. 4A) and
in situ hybridization (Fig. 4B). As noted above, Shh expression
in wild-type retina was restricted to RGCs, and this expression
was dramatically reduced in Brn3b–/– embryos (Fig. 4A,B). 
We also examined the dependency of other components of
the Shh pathway on Brn3b using real-time PCR. Of those
tested, namely, Ptch, Ptch2, Gli2, Gli3 and Smo, only Ptch2
expression was affected in Brn3b–/– retinal RNA. That Ptch2
expression was altered was consistent with a recent report that
loss of Shh signaling mostly affected Ptch2 expression but not
expression of Ptch (Wang et al., 2002b). As reported earlier,
Smo was expressed in progenitor cells in the proliferating zone
of the E14.5 wild-type retina and that expression was unaltered
in the Brn3b–/– retina (Fig. 4B). Taken together, these results
suggest that Brn3b controls the Shh pathway in the retina by
regulating the expression of Shh in RGCs, thereby controlling
the expression of downstream target genes like Gli1 in retinal
progenitor cells. 
To address whether Shh was directly regulated by Brn3b, we
searched for Brn3 DNA-binding sites within a region of the
Shh gene known to contain transcriptional regulatory
sequences capable of driving gene expression in the retina
(Neumann and Nuesslein-Volhard, 2000). By comparing the
Shh genomic sequences of four species (mouse, human,
zebrafish and Fugu), we found a potential Brn3 DNA-binding
site (SBRN3) in a highly conserved 67 bp region in the first
intron of Shh (Fig. 5A). The Brn3 site was completely
conserved in all four species and differed by only one base pair
from the previously reported consensus Brn3b DNA-binding
sequence (Gruber et al., 1997). To determine whether Brn3b
could bind to SBRN3, we performed an electrophoretic
mobility shift assay (EMSA) with a GST fusion protein
containing the POU domain of Brn3b (GST-3bPOU) and an
oligonucleotide probe encompassing SBRN3 (Fig. 5B). GST-
3bPOU formed a specific complex with SBRN3, and formation
of the complex was inhibited by addition of a competitor Brn3b
consensus oligonucleotide or SBRN3 itself, although SBRN3
competition was not as high. The GST-3bPOU-SBRN3
complex was supershifted by an anti-GST antibody (Fig. 5B). 
To characterize further the significance of SBRN3 in
mediating transcriptional activation by Brn3b, we performed
transient co-transfection experiments with HEK 293 cells. We
generated a luciferase reporter construct by placing the
conserved mouse Shh genomic sequence upstream of the
minimal rat prolactin promoter. A mutant reporter construct
was also made in which the nucleotides crucial for Brn3b
binding were changed (Fig. 6). Vectors containing the prolactin
promoter alone or three copies of a known Brn3 consensus
binding site (b3s1) upstream of the prolactin promoter (Trieu
et al., 1999) were used as negative and positive controls,
respectively. Fig. 6 shows the normalized luciferase activity
when the reporter constructs were co-transfected with either a
Brn3b expression plasmid or an empty vector into HEK 239
cells. Brn3b had little effect on the minimal prolactin promoter
alone, but significantly (approximately ninefold) activated
transcription through the control construct containing three
Brn3b-binding sites. As predicted by the EMSA results (Fig.
5), Brn3b activated transcription through the conserved Shh
fragment (eightfold) as strongly as through the known Brn3
consensus site (Fig. 6). When the Brn3b binding site was
mutated, activation by Brn3b was abolished. Although further
confirmation is required, these results suggest that Brn3b
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Fig. 5. Brn3b binds to a conserved element (SBRN3) in the Shh gene. (A) Alignment of a conserved region in the first intron of Shh in mouse,
human, zebrafish and Fugu. Red letters indicate nucleotides not conserved among the species. Percentage of identity for each species when
compared with the mouse sequence is indicated at the end of the sequences. The Brn3b-binding site (SBRN3) is underlined in the mouse
sequence and is completely conserved in all species. The bottom shows the alignment of SBRN3 with the reported consensus Brn3b binding
site. (B) Electrophoretic mobility shift assay using a GST-Brn3b POU fusion protein and a 32P-labeled oligonucleotide probe encompassing
SBRN3. GST-3bPOU formed a specific complex (C), and formation of this complex was strongly inhibited by both an unlabeled Brn3b
consensus oligonucleotide (100 · ) and the SBRN3 oligonucleotide (100 · ). A supershifted complex (S) was formed and retained in the loading
well when anti-GST antibody was added. F is free SBRN3 probe.
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directly regulates Shh expression in RGCs, thereby controlling
Shh signaling in the retina. 
Alterations in gene expression in Brn3b-null retinas
at later developmental stages
The results obtained with E14.5 retina provided new insights
into the downstream events that depend on Brn3b during RGC
differentiation. However, as retina development proceeds, the
loss of Brn3b is likely to lead to additional alterations in gene
expression. To examine later effects, we isolated wild-type and
Brn3b-null RNA from E16.5 and E18.5 retinas and performed
microarray hybridizations. For each stage, two replicate
hybridizations were carried out with two independent pairs of
wild-type and Brn3b-null RNA pools. Genes with fold changes
greater than 1.7 in both duplicate experiments were considered
significant. 
Genes whose expression was significantly altered at
E16.5 and E18.5 were compared with those identified at
E14.5, yielding a total of 280 cDNA clones representing
195 non-redundant genes or ESTs (see Table S2 at
http://dev.biologists.org/supplemental). Four major clusters
(A,B,C and D) emerged from the temporal analysis based on
altered expression patterns in the absence of Brn3b (Fig. 7, see
Table S2 at http://dev.biologists.org/supplemental). Clusters A
and C represented genes that were down- or upregulated,
respectively, in the absence of Brn3b at E14.5, i.e. the Brn3b-
dependent genes that we described in the previous sections.
Alterations in the expression of these genes were likely to be
directly related to the loss of Brn3b rather than to secondary
(and later) effects of aberrant RGC differentiation. Indeed,
many of the E14.5-altered genes were likely to be direct Brn3b
targets. Fig. 7 shows that similar alterations in the expression
of genes in clusters A and B were observed at E16.5 and E18.5,
but overall, the fold change appeared to be less pronounced for
most of the genes. We found that many genes in clusters A and
C were expressed at lower levels at later developmental stages
(data not shown) thus attenuating the fold change in the
microarray analysis. 
Genes in clusters B and D were not significantly affected
at E14.5, but changes in their expression became more
pronounced at later stages, with cluster B representing
downregulated genes and cluster D representing upregulated
ones in the absence of Brn3b (Fig. 7). These genes were not
likely to be affected directly by the absence of Brn3b but rather
by secondary effects, such as abnormal RGC differentiation
and enhanced apoptosis. Most genes in clusters B and D had
unknown functions in retina development and many of them
had matches only to uncharacterized ESTs in GenBank
(see Table S2 at http://dev.biologists.org/supplemental).
Nevertheless, most of the ESTs were derived from neural
tissues, suggesting a function in neural development. 
Genes encoding several transcription factors, including
Zn15, Rpf, A-myb (Mybl1 – Mouse Genome Informatics) and
Tbx20 were represented in clusters B and D. The late Brn3b
dependency on the expression of these genes relative to the
much earlier expression of Brn3b reveal a complex and
dynamic relationship among transcription factors during retina
development. However, the biological significance of the late-
onset alterations in gene expression in Brn3b-null retinas must
still be established.
Discussion
Using microarray technology, we identified discrete sets of
genes that depend on the POU domain transcription factor
Brn3b for their normal levels of expression in the mouse E14.5
retina. Loss of Brn3b and the subsequent defects in RGC
differentiation also caused gene expression alterations at later
stages. Genes affected by the loss of Brn3b at E14.5 were more
likely to be directly related to the function of Brn3b than genes
affected at later times in development. The Brn3b-dependent
gene sets at E14.5 are largely, but not entirely, defined by three
functional classes: genes encoding transcription factors; genes
associated with neuron integrity and function; and genes
encoding secreted signaling molecules. In addition, a number
of other Brn3b-dependent genes were also identified that were
not assigned to these classes, including unknown genes and
uncharacterized ESTs. Notably, we found no alterations in the
expression of genes encoding apoptotic proteins, even though
Brn3b–/– RGCs undergo enhanced apoptosis. This suggests that
the enhanced apoptosis observed in Brn3b-mutant RGCs is
secondary to the initial defects in differentiation.
The identification of Brn3b-dependent genes involved
in neuron integrity and function is consistent with the
differentiation defects observed in Brn3b–/– RGCs. However,
alterations in the expression of some key genes in Brn3b–/–
retinas could not be explained when compared with previous
reports regarding the function of these genes in retinal
development. For example, although cyclin D1 expression was
significantly reduced in the absence of Brn3b, no cell
proliferation or photoreceptor cell defects were observed in
Brn3b-null retinas, as has been reported for cyclin D1-mutant
retinas (Dyer and Cepko, 2001). Similarly, Shh expression was
reduced to very low levels in Brn3b–/– retinas, but neither RGC
P Luc
A
B
C
D
Reporter constructs 
Lu
ci
fe
ra
se
 a
ct
iv
ity
0
1
2
3
4
5
6
Brn3b
1.
4
8.
0
1.
5
9.
2
- + - + - + - +
A B C DReporter
Fig. 6. SBRN3 mediates transcriptional activation by Brn3b in HEK
293 cells. On the left are schematics of the reporter constructs used
in the transfection assay. A contains the minimal rat prolactin
promoter (–36prl) alone (P, green box) upstream of the luciferase
cDNA (Luc); B shows the conserved region (yellow box) in the first
intron of mouse Shh sequence cloned upstream of –36prl; C is the
same as B except that the SBRN3 site is mutated (indicated by a
filled black circle); D contains three copies of the consensus Brn3-
binding site (blue boxes) upstream of –36prl. On the right is the
normalized luciferase activity (in arbitrary units) generated from the
reporter constructs co-transfected into HEK 293 cells, with (+) or
without (–) the Brn3b expression vector. Each bar represents the
average of three replicate experiments. Fold change in luciferase
activity for each construct in the presence of Brn3b is indicated at the
top of the respective bars.
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overproduction nor retinal disorganization were observed, as
would be predicted from Shh gain- or loss-of-function studies
(Neumann and Nuesslein-Volhard, 2000; Wang et al., 2002b;
Zhang and Yang, 2001a; Zhang and Yang, 2001b). One
possible explanation is that in the absence of Brn3b, residual
expression is sufficient for wild-type activity. Alternatively,
Brn3b may regulate molecular events that have opposing
biological effects. Brn3b plays a positive role in RGC
differentiation but it might also inhibit RGC production
through negative-feedback mechanisms involving Shh and
myostatin/Gdf8. In addition, loss of Brn3b might result in
compensating changes in the expression of genes closely
related to genes such as cyclin D1, Shh and myostatin/Gdf8.
The phenotype of Brn3b–/– retinas reflects the net effects of the
deregulation of all Brn3b-dependent genes, which is not
necessarily a simple sum of their phenotypes. 
A major conclusion from our study is that retinal expression
of only a limited number of genes and functional gene
classes was altered in the absence of Brn3b. Eighty-
seven genes were identified with alterations in
expression at E14.5 from a screen of 18,816 retina-
expressed cDNAs, which represented an estimated
12,000 genes (Mu et al., 2001). Given that this number
of genes corresponds to roughly 50% of the total E14.5
retinal transcriptome, we predict that no more than
~200 expressed genes in the E14.5 retina will be
included in the Brn3b-dependent gene sets. 
In general, our analysis did not distinguish between
genes that were under the direct control of Brn3b and
genes that depended on Brn3b only indirectly, through
the action of other transcription factors. Clearly, the
genes encoding Dlx1, Gli1 and cyclin D1 were
indirectly affected because these genes are not
expressed in RGCs, the only retinal cells that express
Brn3b. Furthermore, many genes that are directly
regulated by Brn3b probably have promoter/enhancer
elements that use other transcription factors in addition
to Brn3b, including those transcription factors
identified as Brn3b dependent. The transcriptional
activity of Brn3b has not been clearly defined, although
it appears that Brn3b is capable of transcriptional
activation or repression, depending on the cellular and
promoter context (Budhram-Mahadeo et al., 1999;
Plaza et al., 1999). When measured by real-time PCR,
up- or downregulation of Brn3b-dependent genes
ranged from twice the value observed in wild-type RNA
to more than 40 times, suggesting that a variety of
transcriptional readout mechanisms exist that rely
partly or completely on Brn3b. Positive or negative
feedback mechanisms involving Brn3b-dependent
transcription factors would be interrupted in the
absence of Brn3b and this would also affect
transcriptional readout. Although tightly defined in
terms of number and functional class, the gene
regulatory events downstream of Brn3b are likely to be
exceedingly complex and interconnected.
Because the expression of several genes encoding
transcription factors was significantly affected by the
loss of Brn3b and these regulatory factors would further
alter the expression of other downstream genes, it might
be expected that the gene regulatory network
downstream of Brn3b would extend to hundreds to thousands
of genes. That this was not the case suggests that
transcriptional events independent of Brn3b partially
compensate for the alterations in gene expression caused by the
absence of Brn3b. In fact, many of the identified Brn3b-
dependent genes encoding transcription factors have close
relatives that are expressed in the retina but are apparently not
under the control of Brn3b, Irx5 for example. These genes
could compensate for the reduction in expression of their
Brn3b-dependent relatives. Brn3b clearly represents an
important node in the gene regulatory network that leads to
RGC differentiation because RGCs cannot differentiate
normally without it and most die by P0. By contrast, genes
encoding several important classes of transcription factors that
are known to be expressed in RGCs are not essential for RGC
differentiation as determined by lack of retinal phenotypes in
knockout mice. Gene redundancy may explain the lack of
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Fig. 7. Alterations in Brn3b-dependent gene expression at different stages of
retina development. Each column represents one developmental stage (E14.5,
E16.5 and E18.5) and each horizontal line represents one cDNA clone. Fold
changes (wild type/Brn3b-null) are color-coded according to the bar at the
bottom of the figure; red represents downregulation in Brn3b-null retina and
green represents upregulation. The cDNA clones were clustered according to
similarities their expression patterns as shown by the tree of the right side of
the figure. The four major clusters, A, B, C and D, are discussed in the text. 
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observed RGC phenotypes in many cases, including
redundancy in the Olf/Ebf and Irx gene families (Cohen et al.,
2000; Dubois and Vincent, 2001; Mummenhoff et al., 2001).
Even for Brn3b, significant redundancy exists because more
severe RGC phenotypes are observed in Brn3a–/–; Brn3b–/– and
Brn3b–/–; Brn3c–/– double knockout mice than in Brn3b–/–
single knockout mice (Wang et al., 2002a) (Steven Wang and
W.H.K., unpublished). These results suggest that at least some
Brn3b-dependent genes will be more dramatically affected in
the double knockout retinas because of the partially
overlapping functions of Brn3a, Brn3b and Brn3c. 
The expression of many RGC-specific genes was unaffected
by the loss of Brn3b. Some examples include Pax6, Nf66,
Snap25, and Scg10. Pax6, which is expressed in RGCs at
E14.5, has been reported to be a potential target of Brn3b
(Plaza et al., 1999). Our results suggest that Brn3b is not
essential for Pax6 expression. The results imply that the
expression of these genes must be under the control of RGC
transcription factors that function independently of and parallel
to Brn3b. Control of RGC differentiation thus appears to be
highly robust and adaptable, with both compensatory and
parallel pathways at work to complement the action of Brn3b.
The Brn3b-dependent gene sets thus represent a highly
definable and unique molecular signature for RGCs within the
E14.5 retina. We envision that other RGC transcription factors
will be defined by their own RGC signatures once they are
subjected to similar gene expression profiling analyses.
Ultimately, applying this approach to several key transcription
factors would provide a detailed picture of the entire RGC gene
regulatory network leading from the regulatory genes at the top
of the hierarchy to the terminal downstream genes at the
bottom that define the differentiated cell type. In this regard,
Math5 (Atoh7 – Mouse Genome Informatics), a bHLH
transcription factor expressed in retinal progenitor cells and
essential for RGC specification, is positioned genetically
upstream of Brn3b (Brown et al., 1998; Brown et al., 2001;
Wang et al., 2001). Math5-dependent genes should therefore
include the Brn3b gene sets defined here, intermediate genes
positioned between Math5 and Brn3b, and other genes
associated with the Math5 progenitor cell population. 
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